Ex-Parte Interim Injunction Passed against Symed Laboratories Ltd. for Infringement of Vifor (International) Ltd.’s Patent

An Ex-Parte Interim Injunction was recently passed against Symed Laboratories Ltd. (a Hyderabad based Pharmaceutical Company) by Delhi High Court in a patent infringement suit filed by Vifor (International) AG (a Swiss Pharmaceutical Company). The lawsuit was filed by Vifor against Symed Labs for the infringement of one of Vifor’s Indian granted Patents: IN 221536.

Vifor is a specialty pharmaceutical company focused on the treatment of iron deficiency and offers a number of prescription as well as over-the-counter products and has an iron replacement product portfolio consisting of its products Ferinject®, Venofer®, and Maltofer®. Vifor has about 7 granted patents published at the Indian Patent Office. The Patent in question is on a water-soluble Iron Carbohydrate complex for the treatment of iron deficiency anemia and a process for producing the same. The first claim of the Patent is as follows:

“Water-soluble iron carbohydrate complexes obtainable from an aqueous solution of iron (III) salt and an aqueous solution of the oxidation product of one or more maltodextrins using an aqueous hypochlorite solution at a pH-value within the alkaline range, where, when one maltodextrin is applied, its dextrose equivalent lies between 5 and 20, and when a mixture of several maltodextrins is applied, the dextrose equivalent of the mixture lies between 5 and 20 and the dextrose equivalent of each individual maltodextrin contained in the mixture lies between 2 and 40, wherein the obtained iron complexes have an average molecular weight of 80 kDa to 400 kDa.”

Symed is involved in the manufacture and marketing of bulk pharmaceuticals products, and has launched an alleged infringing product iron carboxymaltose (ferric carboxymaltose) and is also advertising the same at its website. The product of the Vifor’s said patented invention is Ferinject®, an iron complex that consists of a ferric hydroxide core stabilized by a carbohydrate shell, allows for controlled delivery of the iron to target tissues.

The major novelty of the claimed invention seems to lie in average molecular weight of 80 kDa to 400 kDa which has not been disclosed before the priority date of the invention as argued by Vifor’s counsel (as understood from a cursory look of the cited prior arts in the prosecution history of the patent published at the Indian Patent Office). The closest prior art as cited by the examiner disclosed the average molecular weight range of 300-5000. The defendant can study the complete prosecution history of the patent and can try to conduct a strong prior art search especially which covers this molecular range to invalidate the subject patent. The defendant can also study the prosecution history of the family patent applications to see for example, whether or not the same has been granted or not, the kind of prior art references cited therein, the objections made by the examiners, and so forth. This article is being written only to provide information on the passing of this order and not to evaluate whether the patent in question is valid or not and therefore detailed search & analysis on the patent in question is not carried out.

Further, there is an ongoing discussion (for example at Spicy IP) whether the Indian Courts should grant ex-parte injunctions in the patent infringement matters especially where most Indian Judges are not that technically capable to comprehend on their own (they mostly need the assistance of expert witnesses to assess the patent infringement and validity matters). For example, in this order, the Judge did not discuss how denial of an ex-parte order would cause irreparable injury to the Plaintiff and further did not discuss the claims at once.

The complete Order of the Justice Sistani is available here.

 

About the Author: Ms. Meenakshi Khurana, Patent Specialist at Khurana & Khurana and can be reached at meenakshi@khuranaandkhurana.com

Leave a Reply

Your email address will not be published. Required fields are marked *

eight + 9 =

Archives

  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • June 2019
  • May 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017
  • August 2017
  • July 2017
  • June 2017
  • May 2017
  • April 2017
  • March 2017
  • February 2017
  • January 2017
  • December 2016
  • November 2016
  • October 2016
  • September 2016
  • August 2016
  • July 2016
  • June 2016
  • May 2016
  • April 2016
  • March 2016
  • February 2016
  • January 2016
  • December 2015
  • November 2015
  • October 2015
  • September 2015
  • August 2015
  • July 2015
  • June 2015
  • May 2015
  • April 2015
  • March 2015
  • February 2015
  • January 2015
  • December 2014
  • November 2014
  • October 2014
  • September 2014
  • August 2014
  • July 2014
  • June 2014
  • May 2014
  • April 2014
  • March 2014
  • February 2014
  • January 2014
  • December 2013
  • November 2013
  • October 2013
  • September 2013
  • August 2013
  • July 2013
  • June 2013
  • May 2013
  • April 2013
  • March 2013
  • February 2013
  • January 2013
  • December 2012
  • November 2012
  • September 2012
  • August 2012
  • July 2012
  • June 2012
  • May 2012
  • April 2012
  • March 2012
  • February 2012
  • January 2012
  • December 2011
  • November 2011
  • October 2011
  • September 2011
  • August 2011
  • July 2011
  • June 2011
  • May 2011
  • April 2011
  • March 2011
  • February 2011
  • January 2011
  • December 2010
  • September 2010
  • July 2010
  • June 2010
  • May 2010
  • April 2010